eClinical Solutions Releases Newest Version of elluminate®
eClinical Solutions, LLC, a leading provider of data management services and technologies, today announced the release of elluminate®.
eClinical Solutions, a provider of data management services and technologies, announced the release of the latest version of its end to end clinical data repository and analytics platform, elluminate®. The elluminate® platform integrates and standardizes clinical and operational data, regardless of source, to enable advanced analytics and adhoc reporting capabilities. This release enhances the ability to visualize operational data such as metrics, audit trail, and queries to support risk based monitoring and site management. The release also enhances the ability to define workflows to support advanced data integrations. Read the full text here.
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research
May 21st 2025In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.
